Department of Health and Human Services Opens a Narrow Path for Unapproved Peptide Compounding

A draft Department of Health and Human Services policy would let qualifying pharmacies and physicians compound six unapproved peptides under enforcement discretion, despite Food and Drug Administration concerns about limited human evidence and product safety. The panel examines what the policy changes, what the science shows, and whether a controlled supply chain can reduce harm without turning unproven products into routine treatments.

Read the full discussion and sources:

https://factolio.com/?p=3355